41-120-0

SSEA1 Monoclonal Antibody (MC-480), Invitrogen™

Manufacturer: Invitrogen

Select a Size

Pack Size SKU Availability Price
Each of 1 41-120-0-Each-of-1 In Stock ₹ 40,050.00

41-120-0 - Each of 1

₹ 40,050.00

In Stock

Quantity

1

Base Price: ₹ 40,050.00

GST (18%): ₹ 7,209.00

Total Price: ₹ 47,259.00

Antigen

SSEA1

Classification

Monoclonal

Concentration

0.5 mg/mL

Formulation

PBS with 0.1% sodium azide; pH 7.4

Gene Accession No.

P22083, Q11127

Gene Symbols

FUT4

Immunogen

X-irradiated F9 teratocarcinoma stem cells

Quantity

100 μg

Primary or Secondary

Primary

Target Species

Human, Mouse

Product Type

Antibody

Isotype

IgM

Applications

Flow Cytometry, Immunocytochemistry, Western Blot

Clone

MC-480

Conjugate

Unconjugated

Gene

FUT4

Gene Alias

FUTIV, Lewis X, SSEA-1

Host Species

Mouse

Purification Method

Protein A

Regulatory Status

RUO

Gene ID (Entrez)

14345, 2526

Content And Storage

-20°C

Form

Liquid

Related Products

Img

Invitrogen

46-881-342

--

Img

Invitrogen

43-311-0

--

Img

Invitrogen

41-100-0

--

Img

Invitrogen

39-840-1

--

Img

Invitrogen

50-112-2886

--

Img

Invitrogen

41-400-0

--

Img

Invitrogen

50-112-2717

--

Img

Invitrogen

50-112-2686

--

Description

  • CD15 (Lewis X, Le(x); stage specific embryonic antigen-1, SSEA-1) is a trisacharide determinant (3-fucosyl-N-acetyllactosamine) expressed on several glycolipids, glycoproteins and proteoglycans of various cell types, e.g
  • granulocytes, mast cells, monocytes, macrophages, cells of gastric mucosa, nervous system or various tumour cells
  • There are several variants of Lewis x, such as sialyl-Lewis x or sulphated Lewis x
  • Cells with high surface expression of Le(x) antigen exhibit strong self-aggregation, based on calcium-dependent Le(x)-Le(x) interaction
  • This process is involved for example in embryo compaction or in autoaggregation of teratocarcinoma cells
  • Sialyl-Le(x) and its isomer sialyl-Le(a) are ligands of selectins
  • CD15 expression has been extensively used to confirm diagnosis of Hodgkin's disease.